Sarepta Therapeutics to Present Company Overview at the JMP Securities Healthcare Conference on June 24

  Sarepta Therapeutics to Present Company Overview at the JMP Securities
  Healthcare Conference on June 24

             Webcast Accessible via Sarepta Therapeutics Website

JMP Securities Healthcare Conference 2014

Business Wire

CAMBRIDGE, Mass. -- June 18, 2014

Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based
therapeutics, announced today that it is scheduled to present at the JMP
Securities Healthcare Conference in New York, NY on Tuesday, June 24, 2014 at
3:30 p.m. Eastern Time. Chris Garabedian, president and chief executive
officer, will be the presenter.

The presentation will be webcast live on the investor relations section of the
Sarepta Therapeutics website at www.sarepta.com and will be archived under the
events and presentations section following the presentation for 90 days.
Please connect to Sarepta’s website several minutes prior to the start of the
broadcast to ensure adequate time for any software download that may be
necessary.

About Sarepta Therapeutics

Sarepta Therapeutics is focused on developing first-in-class RNA-based
therapeutics to improve and save the lives of people affected by serious and
life-threatening rare and infectious diseases. The Company's diverse pipeline
includes its lead program eteplirsen, for Duchenne muscular dystrophy, as well
as potential treatments for some of the world's most lethal infectious
diseases. Sarepta aims to build a leading, independent biotech company
dedicated to translating its RNA-based science into transformational
therapeutics for patients who face significant unmet medical needs. For more
information, please visit us at www.sarepta.com.

Contact:

Sarepta Investor and Media Contact:
Jim Baker, 617-274-4010
jbaker@sarepta.com
 
Press spacebar to pause and continue. Press esc to stop.